Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001374234 | SCV001571032 | likely benign | Polyglandular autoimmune syndrome, type 1 | 2023-06-09 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001374234 | SCV002076149 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2020-03-20 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003918893 | SCV004735467 | likely benign | AIRE-related disorder | 2020-05-29 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |